The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Multidrug resistance-associated proteins 3, 4, and 5
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Self-citationMammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
Self-citationHuman UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., & Borst, P. (1997) · PubMed · Cited by 882
Self-citationMRP3, an organic anion transporter able to transport anti-cancer drugs
Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M. L., Smith, A. J., Jansen, G., Peters, G. J., Ponne, N., Scheper, R. J., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6914 · Cited by 645
Self-citationThe MRP family of drug efflux pumps
Kruh, G. D., & Belinsky, M. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206953 · Cited by 614
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
Schuetz, J. D., Connelly, M. C., Sun, D., Paibir, S. G., Flynn, P. M., Srinivas, R. V., Kumar, A., & Fridland, A. (1999) · Nature Medicine · doi:10.1038/12487 · Cited by 575
Predicting drug sensitivity and resistance
Szakács, G., Annereau, J.-P., Lababidi, S., Shankavaram, U., Arciello, A., Bussey, K. J., Reinhold, W., Guo, Y., Kruh, G. D., Reimers, M., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.026 · Cited by 531
König, J., Rost, D., Cui, Y., & Keppler, D. (1999) · Hepatology · doi:10.1002/hep.510290404 · Cited by 504
van Aubel, R. A. M. H., Smeets, P. H. E., Peters, J. G. P., Bindels, R. J. M., & Russel, F. G. M. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133595 · Cited by 501
Haimeur, A., Conseil, G., Deeley, R., & Cole, S. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489199 · Cited by 485
Wijnholds, J., Mol, C. A. A. M., van Deemter, L., de Haas, M., Scheffer, G. L., Baas, F., Beijnen, J. H., Scheper, R. J., Hatse, S., De Clercq, E., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120159197 · Cited by 478
Self-citationReid, G., Wielinga, P., Zelcer, N., van der Heijden, I., Kuil, A., de Haas, M., Wijnholds, J., & Borst, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1033060100 · Cited by 463
Self-citationThe Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides
Jedlitschky, G., Burchell, B., & Keppler, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005463200 · Cited by 442
Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy
Leggas, M., Adachi, M., Scheffer, G. L., Sun, D., Wielinga, P., Du, G., Mercer, K. E., Zhuang, Y., Panetta, J. C., Johnston, B., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7612-7621.2004 · Cited by 414
Transport of Cyclic Nucleotides and Estradiol 17-β-d-Glucuronide by Multidrug Resistance Protein 4
Chen, Z.-S., Lee, K., & Kruh, G. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104833200 · Cited by 396
Nies, A. T., Jedlitschky, G., König, J., Herold-Mende, C., Steiner, H. H., Schmitt, H.-P., & Keppler, D. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.051 · Cited by 379
Reid, G., Wielinga, P., Zelcer, N., de Haas, M., van Deemter, L., Wijnholds, J., Balzarini, J., & Borst, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1094 · Cited by 368
Self-citationABC proteins : from bacteria to man
Holland, I. B., Cole, S. P. C., Kuchler, K., & Higgins, C. F. (2003) · Medical Entomology and Zoology · Cited by 361
Hirohashi, T., Suzuki, H., & Sugiyama, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15181 · Cited by 347
ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)
Hirohashi, T., Suzuki, H., Takikawa, H., & Sugiyama, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2905 · Cited by 338
Schuetz, E. G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J., Kim, R. B., Ramachandran, V., Komoroski, B. J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106340200 · Cited by 334
Allikmets, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1649 · Cited by 334
Rius, M., Nies, A. T., Hummel-Eisenbeiss, J., Jedlitschky, G., & Keppler, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50331 · Cited by 324
Chen, Z., Lee, K., WALTHER, S. E., Raftogianis, R. B., Kuwano, M., Zeng, H., & Kruh, G. D. (2002) · PubMed · Cited by 316
Up–Regulation of Basolateral Multidrug Resistance Protein 3 (Mrp3) in Cholestatic Rat Liver
Donner, M. G., & Keppler, D. (2001) · Hepatology · doi:10.1053/jhep.2001.26213 · Cited by 292
ZELCER, N., REID, G., WIELINGA, P., KUIL, A., van der HEIJDEN, I., SCHUETZ, J. D., & BORST, P. (2003) · Biochemical Journal · doi:10.1042/bj20021886 · Cited by 281
Self-citationAdaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis
Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H.-U., Zatloukal, K., Denk, H., & Trauner, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00096-5 · Cited by 275
Characterization of the MRP4- and MRP5-mediated Transport of Cyclic Nucleotides from Intact Cells
Wielinga, P. R., van der Heijden, I., Reid, G., Beijnen, J. H., Wijnholds, J., & Borst, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212723200 · Cited by 266
Self-citationTissue Distribution and Induction of Human Multidrug Resistant Protein 3
Scheffer, G. L., Kool, M., de Haas, M., de Vree, J. M. L., Pijnenborg, A. C. L. M., Bosman, D. K., Oude Elferink, R. P. J., van der Valk, P., Borst, P., & Scheper, R. J. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780411 · Cited by 266
Self-citationHirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., & Sugiyama, Y. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13278-6 · Cited by 266
Characterization of Drug Transport by the Human Multidrug Resistance Protein 3 (ABCC3)
Zelcer, N., Saeki, T., Reid, G., Beijnen, J. H., & Borst, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107041200 · Cited by 258
Self-citationMaher, J. M., Cheng, X., Slitt, A. L., Dieter, M. Z., & Klaassen, C. D. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003798 · Cited by 255
Characterization of inducible nature of MRP3 in rat liver
Ogawa, K., Suzuki, H., Hirohashi, T., Ishikawa, T., Meier, P. J., Hirose, K., Akizawa, T., Yoshioka, M., & Sugiyama, Y. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.3.g438 · Cited by 253
Van Aubel, R. A. M. H., Smeets, P. H. E., van den Heuvel, J. J. M. W., & Russel, F. G. M. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00133.2004 · Cited by 246
Hepatic Secretion of Conjugated Drugs and Endogenous Substances
KEPPLER, D., & KÖNIG, J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9391 · Cited by 245
Pratt, S., Shepard, R. L., Kandasamy, R. A., Johnston, P. A., Perry, W., & Dantzig, A. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0291 · Cited by 245
Assem, M., Schuetz, E. G., Leggas, M., Sun, D., Yasuda, K., Reid, G., Zelcer, N., Adachi, M., Strom, S., Evans, R. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314111200 · Cited by 240
Self-citationAllen, J. D., Brinkhuis, R. F., van Deemter, L., Wijnholds, J., & Schinkel, A. H. (2000) · PubMed · Cited by 236
Transport of amphipathic anions by human multidrug resistance protein 3.
Zeng, H., Liu, G., Rea, P. A., & Kruh, G. D. (2000) · PubMed · Cited by 235
Analysis of the MRP4 Drug Resistance Profile in Transfected NIH3T3 Cells
Lee, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1934 · Cited by 222
Zelcer, N., van de Wetering, K., Hillebrand, M., Sarton, E., Kuil, A., Wielinga, P. R., Tephly, T., Dahan, A., Beijnen, J. H., & Borst, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502530102 · Cited by 215
Self-citationThe role of multidrug transporters in drug availability, metabolism and toxicity
Bodó, A., Bakos, É., Szeri, F., Váradi, A., & Sarkadi, B. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00497-6 · Cited by 214
cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)1
Kiuchi, Y., Suzuki, H., Hirohashi, T., Tyson, C. A., & Sugiyama, Y. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00899-0 · Cited by 213
Zelcer, N., Huisman, M. T., Reid, G., Wielinga, P., Breedveld, P., Kuil, A., Knipscheer, P., Schellens, J. H. M., Schinkel, A. H., & Borst, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303504200 · Cited by 200
Self-citationMcAleer, M. A., Breen, M. A., White, N. L., & Matthews, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23541 · Cited by 196
Maher, J. M., Slitt, A. L., Cherrington, N. J., Cheng, X., & Klaassen, C. D. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003780 · Cited by 195
König, J., Hartel, M., Nies, A. T., Martignoni, M. E., Guo, J., Büchler, M. W., Friess, H., & Keppler, D. (2005) · International Journal of Cancer · doi:10.1002/ijc.20831 · Cited by 194
Zelcer, N., Wetering, K. V. D., Waart, R. D., Scheffer, G. L., Marschall, H.-U., Wielinga, P. R., Kuil, A., Kunne, C., Smith, A., Valk, M. V. D., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.07.022 · Cited by 181
Self-citationJedlitschky, G., Tirschmann, K., Lubenow, L. E., Nieuwenhuis, H. K., Akkerman, J. W. N., Greinacher, A., & Kroemer, H. K. (2004) · Blood · doi:10.1182/blood-2003-12-4330 · Cited by 181
Wielinga, P. R., Reid, G., Challa, E. E., van der Heijden, I., van Deemter, L., de Haas, M., Mol, C., Kuil, A. J., Groeneveld, E., Schuetz, J. D., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1321 · Cited by 179
Self-citationZhang, Y., Schuetz, J. D., Elmquist, W. F., & Miller, D. W. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068528 · Cited by 175
Boumendjel, A., Baubichon-Cortay, H., Trompier, D., Perrotton, T., & Pietro, A. D. (2005) · Medicinal Research Reviews · doi:10.1002/med.20032 · Cited by 175
Zeng, H., Bain, L. J., Belinsky, M. G., & Kruh, G. D. (1999) · PubMed · Cited by 173
Belinsky, M. G., Bain, L. J., Balsara, B. B., Testa, J. R., & Kruh, G. D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.22.1735 · Cited by 170
Young, L. C., Campling, B. G., Voskoglou-Nomikos, T., Cole, S. P. C., Deeley, R. G., & Gerlach, J. H. (1999) · PubMed · Cited by 168
Analysis of the In Vivo Functions of Mrp3
Belinsky, M. G., Dawson, P. A., Shchaveleva, I., Bain, L. J., Wang, R., Ling, V., Chen, Z.-S., Grinberg, A., Westphal, H., Klein-Szanto, A., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010587 · Cited by 168
Bodó, A., Bakos, É., Szeri, F., Váradi, A., & Sarkadi, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303515200 · Cited by 166
Rost, D., Mahner, S., Sugiyama, Y., & Stremmel, W. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00318.2001 · Cited by 166
Wu, C., Calcagno, A. M., Hladky, S. B., Ambudkar, S. V., & Barrand, M. A. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04888.x · Cited by 159
Liqi, L. A. I., & Tan, T. M. C. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610497 · Cited by 158
Wielinga, P. R., Hooijberg, J. H., Gunnarsdottir, S., Kathmann, I., Reid, G., Zelcer, N., van der Born, K., de Haas, M., van der Heijden, I., Kaspers, G. J. L., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2810 · Cited by 156
Self-citationBohan, A., Chen, W., Denson, L. A., Held, M. A., & Boyer, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304011200 · Cited by 151
Lee, K., Belinsky, M. G., Bell, D. W., Testa, J. R., & Kruh, G. D. (1998) · PubMed · Cited by 149
INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
Teng, S., Jekerle, V., & Piquette‐Miller, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1296 · Cited by 148
Denk, G. U., Soroka, C. J., Takeyama, Y., Chen, W.-S., Schuetz, J. D., & Boyer, J. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.001 · Cited by 147
Smeets, P. H. E., van Aubel, R. A. M. H., Wouterse, A. C., van den Heuvel, J. J. M. W., & Rüssel, F. G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000143473.64430.ac · Cited by 146
Rius, M., Hummel-Eisenbeiss, J., Hofmann, A. F., & Keppler, D. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00354.2005 · Cited by 144
Norris, M. D., Smith, J. L., Tanabe, K. M., Tobin, P. J., Flemming, C. L., Scheffer, G. L., Wielinga, P. R., Cohn, S. L., London, W. B., Marshall, G. M., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0161 · Cited by 138
Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell Killing
Adachi, M., Sampath, J., Lan, L.-B., Sun, D., Hargrove, P., Flatley, R. M., Tatum, A., Edwards, M. Z., Wezeman, M. J., Matherly, L. H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203262200 · Cited by 135
Pfrunder, A., Gutmann, H., Beglinger, C., & Drewe, J. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2003.tb02434.x · Cited by 134
Aleksunes, L. M., Slitt, A. L., Cherrington, N. J., Thibodeau, M. S., Klaassen, C. D., & Manautou, J. E. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi013 · Cited by 132
Enhanced Expression of the Human Multidrug Resistance Protein 3 by Bile Salt in Human Enterocytes
Inokuchi, A., Hinoshita, E., Iwamoto, Y., Kohno, K., Kuwano, M., & Uchiumi, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104612200 · Cited by 130
Efflux transport systems for organic anions and cations at the blood?CSF barrier
Kusuhara, H., & Sugiyama, Y. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.007 · Cited by 117
Lang, T., Hitzl, M., Burk, O., Mornhinweg, E., Keil, A., Kerb, R., Klein, K., Zanger, U. M., Eichelbaum, M. F., & Fromm, M. F. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00003 · Cited by 116
zu Schwabedissen, H. E. M., Grube, M., Heydrich, B., Linnemann, K., Fusch, C., Kroemer, H. K., & Jedlitschky, G. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62230-4 · Cited by 114
Johnson, B. M., Zhang, P., Schuetz, J. D., & Brouwer, K. L. R. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005793 · Cited by 114
Dazert, P., Meissner, K., Vogelgesang, S., Heydrich, B., Eckel, L., Böhm, M., Warzok, R., Kerb, R., Brinkmann, U., Schaeffeler, E., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63513-4 · Cited by 112
Zelcer, N., SAEKI, T., Ilse, B. O. T., Kuil, A., & Borst, P. (2002) · Biochemical Journal · doi:10.1042/bj20021081 · Cited by 110
Self-citationChu, X., Huskey, S. W., Braun, M. P., Sarkadi, B., Evans, D. C., & Evers, R. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062091 · Cited by 110
MRP2 and 3 in health and disease
Borst, P., Zelcer, N., & van de Wetering, K. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.05.051 · Cited by 107
Self-citationSager, G. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2004.03.017 · Cited by 106
The (patho)physiological functions of the MRP family.
Renes, J., de Vries, E. D., Jansen, P., & Müller, M. (2000) · Drug resistance updates · doi:10.1054/drup.2000.0156 · Cited by 105
Altered Disposition of Acetaminophen in Mice With a Disruption of the Mrp3 Gene * #
Manautou, J. E., de Waart, D. R., Kunne, C., Zelcer, N., Goedken, M. J., Borst, P., & Elferink, R. P. J. O. (2005) · Hepatology · doi:10.1002/hep.20898 · Cited by 104
Self-citationRius, M., Thon, W., KEPPLER, D. O. R., & Nies, A. T. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000180411.03808.cb · Cited by 99
Steinbach, D., Wittig, S., Cario, G., Viehmann, S. F., Mueller, A. H., Gruhn, B., Haefer, R., Zintl, F., & Sauerbrey, A. (2003) · Blood · doi:10.1182/blood-2002-11-3461 · Cited by 93
Dallas, S., Schlichter, L. C., & Bendayan, R. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063966 · Cited by 92
Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes.
Radominska-p, A., Zimniak, P., Irshaid, Y. M., Lester, R., Tephly, T. R., & Pyrek, J. S. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113053 · Cited by 90
Slitt, A. L., Cherrington, N. J., Maher, J. M., & Klaassen, C. D. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1176 · Cited by 87
Aleksunes, L. M., Scheffer, G. L., Jakowski, A. B., Pruimboom‐Brees, I., & Manautou, J. E. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi332 · Cited by 85
Lee, Y.-M. A., Cui, Y., K??nig, J., Risch, A., ger, B. J., Drings, P., Bartsch, H., KEPPLER, D. O. R., & Nies, A. T. (2004) · Pharmacogenetics · doi:10.1097/00008571-200404000-00001 · Cited by 80
Xiong, H., Suzuki, H., Sugiyama, Y., Meier, P. J., Pollack, G. M., & Brouwer, K. L. R. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.9.962 · Cited by 78
Intestinal absorption, excretion, and biotransformation of hyodeoxycholic acid in man.
SACQUET, E., Parquet, M., Riottot, M., et al. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37965-7 · Cited by 70
Adachi, M., Reid, G., & Schuetz, J. D. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00166-7 · Cited by 67
cGMP and glutathione‐conjugate transport in human erythrocytes
Klokouzas, A., Wu, C., van Veen, H. W., Barrand, M. A., & Hladky, S. B. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03753.x · Cited by 64
Immunolocalization of Multidrug Resistance Protein 5 in the Human Genitourinary System
Nies, A. T., Spring, H., Thon, W., KEPPLER, D. O. R., & Jedlitschky, G. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65141-5 · Cited by 60
The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy
Borst, P., Balzarini, J. M., Ono, N., Reid, G., de Vries, H., Wielinga, P. R., Wijnholds, J., & Zelcer, N. (2003) · Antiviral Research · doi:10.1016/j.antiviral.2003.11.002 · Cited by 59
Self-citationCherrington, N. J., Slitt, A. L., Maher, J. M., Zhang, X.-X., Zhang, J., Huang, W., Wan, Y. Y., Moore, D. D., & Klaassen, C. D. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1315 · Cited by 59
Schultz, C., Vaskinn, S., Kildalsen, H., & Sager, G. (1998) · Biochemistry · doi:10.1021/bi9713409 · Cited by 55
Up-regulation of Mrp4 expression in kidney of Mrp2-deficient TR− rats
Chen, C., Slitt, A. L., Dieter, M. Z., Tanaka, Y., Scheffer, G. L., & Klaassen, C. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.06.019 · Cited by 54
Haga, S., Hinoshita, E., Ikezaki, K., Fukui, M., Scheffer, G. L., Uchiumi, T., & Kuwano, M. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01084.x · Cited by 52
Ishikawa, T., Kuo, M. T., Furuta, K., & Suzuki, M. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.130 · Cited by 52
Pratt, S. E., Chen, V., Perry, W. I., Starling, J. J., & Dantzig, A. H. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.09.012 · Cited by 51
Ghanem, C. I., Ruiz, M. L., Villanueva, S. S. M., Luquita, M. G., Catania, V. A., Jones, B. R., Bengochea, L. A., Vore, M. E., & Mottino, A. D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090613 · Cited by 47
MRP2, THE APICAL EXPORT PUMP FOR ANIONIC CONJUGATES
König, J., Nies, A. T., Cui, Y., & KEPPLER, D. O. R. (2003) · Elsevier eBooks · doi:10.1016/b978-012352551-2/50021-4 · Cited by 45
Pharmacogenetics of hepatocellular transporters
Pauli‐Magnus, C., & Meier, P. J. (2003) · Pharmacogenetics · doi:10.1097/00008571-200304000-00003 · Cited by 40
Human Red Blood Cells: Rheological Aspects, Uptake, and Release of Cytotoxic Drugs
Dumez, H., Reinhart, W. H., Guetens, G., & de Bruijn, E. A. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490452031 · Cited by 34
cGMP (guanosine 3′,5′-cyclic monophosphate) transport across human erythrocyte membranes
Wu, C., Woodcock, H. V., Hladky, S. B., & Barrand, M. A. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.005 · Cited by 22
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
What do drug transporters really do?
Nigam, S. K. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4461 · Cited by 527
An overview of cancer multidrug resistance: a still unsolved problem
Lage, H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8111-5 · Cited by 408
RUSSEL, F., KOENDERINK, J., & MASEREEUW, R. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.006 · Cited by 383
PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses
Mazaleuskaya, L. L., Sangkuhl, K., Thorn, C. F., FitzGerald, G. A., Altman, R. B., & Klein, T. E. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000150 · Cited by 379
Metadata
- Authors
- Borst, P., de Wolf, C., & van de Wetering, K.
- Venue
- Pflügers Archiv - European Journal of Physiology
- Published
- 2006-04-04
- Volume
- 453
- Issue
- 5
- Pages
- 661-673
- ISSN
- 0031-6768 (ISSN-L)
- 1432-2013
- OpenAlex
- W2142030049
- Cited by
- 299
- References
- 108
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.